Skip to main content
SpringerLink
Log in

Aktueller Malariaschutz bei Kurzzeitaufenthalt

Malaria protection for short-term travelers

  • Schwerpunkt: Parasitosen
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

In Deutschland werden jährlich ca. 800 Malariafälle gemeldet. Für ca. 1% der nicht immunen Reisenden endet die Krankheit tödlich. Um diese Situation zu verbessern, ist die Information durch die beratenden Ärzte entscheidend: das Risikobewusstsein der Reisenden vor, während und nach einer Reise in endemische Gebiete muss geschärft werden. Ein konsequenter Mückenschutz vermindert das Infektionsrisiko der Malaria sowie anderer durch Arthropoden übertragener Krankheiten zusätzlich. Die regelmäßige Einnahme von Medikamenten zur Malariachemoprophylaxe in Hochrisikogebieten sowie das rasche Handeln im Falle von Fieber in Gebieten mit mäßigem oder kleinem Malariarisiko (Aufsuchen eines Arztes zur Diagnosestellung, notfalls Selbsttherapie) tragen wesentlich zur Reduktion schwerer Malariaerkrankungen bei.

Abstract

An average of 800 malaria cases are recorded annually in Germany. One person in a hundred dies of the disease. Travel advice given by experienced physicians is essential to raise awareness of malaria risk in endemic areas. Rational mosquito protection on skin and textiles reduces the risk of malaria and other arthropod-transmitted diseases (e. g. dengue fever). Regular intake of an antimalarial drugs to suppress the development forms the basis of reliable chemo prophylaxis in highly endemic areas. The concept of standby emergency treatment (SET) in areas of low or moderate risk needs to be communicated in a detailed and clear way: take the temperature when feeling unwell; seeing a doctor immediately if a fever arises after 6 days of stay in an area, intake of SET if a doctor can not be reached within 24 hours; see a doctor after taking the SET as quickly as possible. These elements help to reduce the rate of severe malaria cases among travelers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Angell SY, Behrens RH (2005) Risk assessment and disease prevention in travelers visiting friends and relatives. Infect Dis Clin North Am 19: 49–65

    Article  PubMed  Google Scholar 

  2. Askling HH, Nilsson J, Tegnell A et al. (2005) Malaria risk in travellers. Emerg Inf Dis 11: 436–441

    Google Scholar 

  3. Behrens RH, Bisoffi Z, Bjorkman A et al. (2006) Malaria prophylaxis policy for travellers from Europe to the Indian subcontinent. Malar J 5: 7

    Article  PubMed  Google Scholar 

  4. Dos Santos CC, Anvar A, Keystone JS, Kain KC (1999) Survey of use of malaria prevention measures by Canadians visiting India. CMAJ 160: 195–200

    PubMed  Google Scholar 

  5. Hatz C, Abdulla S, Mull R et al. (1998) Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat falciparum malaria in Tanzanian children aged 1–5 years. Trop Med Int Health 3: 498–504

    Article  PubMed  Google Scholar 

  6. Hatz C, Nothdurft HD, Gay F et al. (2005) Open-label, uncontrolled multi-center study of the efficacy and safety of Coartem®/Riamet® in the treatment of acute, uncomplicated P. falciparum malaria in non-immune travellers. Proceedings of the XVIth International Congress for Tropical Medicine and Malaria, Marseille 2005; 144: 65

  7. Kain KC, Keystone JS (1998) Malaria in travelers: epidemiology, disease, and prevention. Infect Dis Clin North Am 12: 267–284

    Article  PubMed  Google Scholar 

  8. Muentener P, Schlagenhauf P, Steffen R (1999) Imported malaria (1985–95): trends and perspectives. Bull WHO 77: 560–566

    PubMed  Google Scholar 

  9. Leder K, Black J, O’Brien D et al. (2004) Malaria in travellers: a review of the GeoSentinel surveillance network. Clin Infect Dis 39: 1104–1112

    Article  PubMed  Google Scholar 

  10. Lehky Hagen M, Haley TJL, Hatz C (2005) Factors influencing the pattern of imported malaria. J Travel Med 12: 72–79

    PubMed  Google Scholar 

  11. Miller SA, Bergmann BP, Croft AM (1999) Epidemiology of malaria in the British Army from 1982–1986. J R Army Med Corps 145: 20–22

    PubMed  Google Scholar 

  12. Nothdurft HD, Jelinek T, Bluml A et al. (1999) Seroconversion to circumsporoite antigen of Plasmodium falciparum demonstrates a high risk of malaria transmission in travelers to East Africa. Clin Infect Dis 28: 641–641

    PubMed  Google Scholar 

  13. Oehler T, Büchel B, Hatz C, Furrer HJ (2000) Beratung HIV-Infizierter vor Reisen in tropische und subtropische Gebiete. Schweiz Med Wochenschr 130: 1041–1050

    PubMed  Google Scholar 

  14. Ryan ET, Kain KC (2000) Health advice and immunizations for travellers. N Engl J Med 342: 1716–1725

    Article  PubMed  Google Scholar 

  15. Schlagenhauf P (1999) Mefloquine for malaria chemoprophylaxis 1992–1998: a review. J Travel Med 6: 122–133

    PubMed  Google Scholar 

  16. Schlagenhauf P, Tschopp A, Johnson R et al. (2003) Tolerability of malaria chemoprophylaxis in non-immune travelers to Sub-saharan Africa: a randomised, double-blind, four-arm study. BMJ 327: 1078

    Article  PubMed  Google Scholar 

  17. Steffen R, Fuchs E, Schildknecht J et al. (1993) Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 341: 1299–1303

    Article  PubMed  Google Scholar 

  18. Van der Berg JD, Duvenage CS, Roskell NS, Scott TR (1999) Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa. Clin Ther 21: 741–749

    Article  PubMed  Google Scholar 

  19. Weinke T, Trautmann M, Held T (1991) Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 45: 86–91

    PubMed  Google Scholar 

  20. Wichmann O, Betschart B, Löscher T et al. (2003) Prophylaxis failure due to probable mefloquine resistant P. falciparum from Tanzania. Acta Trop 86: 63–65

    Article  PubMed  Google Scholar 

Download references

Danksagung.

Spezieller Dank geht an die Mitarbeiter der erweiterten Schweizerischen Arbeitsgruppe für Reisemedizin: B. Beck und J. Blum, Basel; C. Bourquin, Bern; F. Brenneke, Basel; M. Funk, Zürich; H. Furrer, Bern; B. Genton, Lausanne; B. Holzer, Bern; L. Loutan, Genf; P.-A. Raeber, Bern; W. Rudin, Basel; P. Schlagenhauf, R. Steffen, und U. Stössel, Zürich; E. Jeschko, Wien.

Interessenkonflikt

Es besteht kein Interessenkonflikt. Die Autoren haben Zuwendungen für Vorträge bei Fortbildungsveranstaltungen von GSK, Novartis, Berna Biotech, Sanofi Pasteur erhalten. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produkteneutral.

Author information

Authors and Affiliations

  1. Schweizerisches Tropeninstitut, Postfach, 4002, Basel, Schweiz

    C. F. R. Hatz

  2. Universität München

    H. D. Nothdurft

Authors
  1. C. F. R. Hatz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. D. Nothdurft
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. F. R. Hatz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hatz, C.F.R., Nothdurft, H.D. Aktueller Malariaschutz bei Kurzzeitaufenthalt. Internist 47, 810–817 (2006). https://doi.org/10.1007/s00108-006-1653-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-006-1653-4

Schlüsselwörter

Keywords

Search

Navigation